CAS RN: 453555-03-8
2-(5-Amino-[1,3,4]thiadiazol-2-ylsulfanyl)-N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-propionamide
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 453555-03-8
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shanghai
Inquiry
453555-03-8 / 2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-N-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)propanamide
Standard CAS: 453555-03-8
Multi CAS: No
Basic Information
copy
CAS
453555-03-8 copy
Multi CAS
No copy
Molecular Formula
C16H18N6O2S2 copy
Molecular Weight
390.500000 copy
Exact Mass
390.093266 copy
InChI
InChI=1S/C16H18N6O2S2/c1-9-12(14(24)22(21(9)3)11-7-5-4-6-8-11)18-13(23)10(2)25-16-20-19-15(17)26-16/h4-8,10H,1-3H3,(H2,17,19)(H,18,23) copy
InChIKey
SSBKHOFUKIKJGH-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
26 copy
Aromatic heavy atom count
16 copy
Fraction Csp3
0.25 copy
Rotatable bonds
5 copy
H-bond acceptors
9 copy
H-bond donors
2 copy
Molar refractivity
104.02 copy
TPSA
107.83 copy
LogP / Solubility
WLOGP
2.04 copy
MLOGP
1.82 copy
XLogP3
2.4 copy
Consensus LogP
2.09 copy
Log S (ESOL)
-3.67 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-4.23 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-4.49 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.66 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
3 copy